Patent Ductus Arteriosus — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for patent ductus arteriosus. 20 active patents protecting 2 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
20
Active US patents
63/100
Avg vulnerability
Annual revenue covered

Originators in Patent Ductus Arteriosus

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Boots Group) 14 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating patent ductus arteriosus. Each bar = one year. Y-axis scaled to peak year (8 patents).

8
29
8
30
4
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Advil
ibuprofen
Generic (originally Boots Group) 14 70 2029-09-30
Indocin Sr
INDOMETHACIN
6 56 2030-04-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11806400 Advil method of use 76 2032-03-16
11806400 Advil method of use 76 2032-03-16
8871810 Advil method of use 73 2029-09-30
8735452 Advil method of use 73 2029-09-30
9649284 Advil method of use 68 2029-09-30
9295639 Advil method of use 68 2029-09-30
8735452 Advil method of use 68 2029-09-30
9138404 Advil method of use 68 2029-09-30
9114068 Advil method of use 68 2029-09-30
8871810 Advil method of use 68 2029-09-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8992982 Indocin Sr formulation 48 2030-04-23
8992982 Indocin Sr formulation 48 2030-04-23
8734847 Indocin Sr formulation 53 2030-04-23
8734847 Indocin Sr formulation 53 2030-04-23
9072661 Advil method of use 68 2032-03-16
9072710 Advil method of use 68 2032-03-16
9012508 Advil method of use 68 2030-09-14
9012508 Advil method of use 68 2030-09-14
9089471 Indocin Sr method of use 68 2030-04-23
9089471 Indocin Sr method of use 68 2030-04-23

Related